64 related articles for article (PubMed ID: 18180118)
1. Single- and multiple-dose pharmacokinetics of exendin-4 in rhesus monkeys.
Ai G; Chen Z; Shan C; Che J; Hou Y; Cheng Y
Int J Pharm; 2008 Apr; 353(1-2):56-64. PubMed ID: 18180118
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and hematological effects of the PEGylated thrombopoietin peptide mimetic GW395058 in rats and monkeys after intravenous or subcutaneous administration.
de Serres M; Yeager RL; Dillberger JE; Lalonde G; Gardner GH; Rubens CA; Simkins AH; Sailstad JM; McNulty MJ; Woolley JL
Stem Cells; 1999; 17(6):316-26. PubMed ID: 10606160
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of His-tag recombinant human endostatin in Rhesus monkeys.
Song HF; Liu XW; Zhang HN; Zhu BZ; Yuan SJ; Liu SY; Tang ZM
Acta Pharmacol Sin; 2005 Jan; 26(1):124-8. PubMed ID: 15659125
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of exenatide following alternate routes of administration.
Gedulin BR; Smith PA; Jodka CM; Chen K; Bhavsar S; Nielsen LL; Parkes DG; Young AA
Int J Pharm; 2008 May; 356(1-2):231-8. PubMed ID: 18291606
[TBL] [Abstract][Full Text] [Related]
6. Target-mediated pharmacokinetic and pharmacodynamic model of exendin-4 in rats, monkeys, and humans.
Gao W; Jusko WJ
Drug Metab Dispos; 2012 May; 40(5):990-7. PubMed ID: 22338110
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and peripheral platelet counts after a single dose of recombinant human thrombopoietin in rhesus monkeys.
Song HF; Liu XW; Tang ZM
Zhongguo Yao Li Xue Bao; 1999 Mar; 20(3):244-8. PubMed ID: 10452100
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of recombinant human interleukin-12 in male rhesus monkeys.
Nadeau RR; Ostrowski C; Ni-Wu G; Liberato DJ
J Pharmacol Exp Ther; 1995 Jul; 274(1):78-83. PubMed ID: 7616451
[TBL] [Abstract][Full Text] [Related]
9. A new approach for pharmacokinetics of single-dose cetuximab in rhesus monkeys by surface plasmon resonance biosensor.
Che J; Wang H; Chen Z; Li X; Hou Y; Shan C; Cheng Y
J Pharm Biomed Anal; 2009 Sep; 50(2):183-8. PubMed ID: 19446977
[TBL] [Abstract][Full Text] [Related]
10. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study.
Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD
Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789
[TBL] [Abstract][Full Text] [Related]
11. Lack of dose dependent kinetics of methyl salicylate-2-O-β-D-lactoside in rhesus monkeys after oral administration.
He Y; Yan Y; Zhang T; Ma Y; Zhang W; Wu P; Song J; Wang S; Du G
J Ethnopharmacol; 2015 Apr; 164():293-300. PubMed ID: 25571846
[TBL] [Abstract][Full Text] [Related]
12. Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes.
Linnebjerg H; Park S; Kothare PA; Trautmann ME; Mace K; Fineman M; Wilding I; Nauck M; Horowitz M
Regul Pept; 2008 Nov; 151(1-3):123-9. PubMed ID: 18675854
[TBL] [Abstract][Full Text] [Related]
13. A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: a randomized, double-blind, two-period crossover study in healthy volunteers.
Darwish M; Chang S; Hellriegel ET
Clin Ther; 2009 Jan; 31(1):108-14. PubMed ID: 19243711
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of primaquine in rhesus monkeys.
Prasad RN; Garg SK; Mahajan RC; Ganguly NK
Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):45-6. PubMed ID: 3988392
[TBL] [Abstract][Full Text] [Related]
15. Enantioselective pharmacokinetics of racemic carprofen in New Zealand white rabbits.
Hawkins MG; Taylor IT; Craigmill AL; Tell LA
J Vet Pharmacol Ther; 2008 Oct; 31(5):423-30. PubMed ID: 19000261
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic, pharmacodynamic, and efficacy profiles of alogliptin, a novel inhibitor of dipeptidyl peptidase-4, in rats, dogs, and monkeys.
Lee B; Shi L; Kassel DB; Asakawa T; Takeuchi K; Christopher RJ
Eur J Pharmacol; 2008 Jul; 589(1-3):306-14. PubMed ID: 18538760
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
18. Interspecies modeling and prediction of human exenatide pharmacokinetics.
Chen T; Mager DE; Kagan L
Pharm Res; 2013 Mar; 30(3):751-60. PubMed ID: 23229855
[TBL] [Abstract][Full Text] [Related]
19. Exendin-4 Loaded Nanoparticles with a Lipid Shell and Aqueous Core Containing Micelles for Enhanced Intestinal Absorption.
Chen C; Zhu X; Dou Y; Xu J; Zhang J; Fan T; Du J; Liu K; Deng Y; Zhao L; Huang Y
J Biomed Nanotechnol; 2015 May; 11(5):865-76. PubMed ID: 26349398
[TBL] [Abstract][Full Text] [Related]
20. Determination of glycyrrhetic acid in human plasma by HPLC-MS method and investigation of its pharmacokinetics.
Zhao WJ; Wang BJ; Wei CM; Yuan GY; Bu FL; Guo RC
J Clin Pharm Ther; 2008 Jun; 33(3):289-94. PubMed ID: 18452416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
